Medical Device Cybersecurity: The Hidden Risk in Every Clinical Environment
There are estimated to be over 500,000 connected medical devices on NHS networks — most running operating systems that cannot be updated, communicating on protocols designed decades before cybersecurity was a consideration, and managed by clinical staff rather than IT professionals. When a pacemaker or insulin pump can theoretically be accessed remotely, the stakes of poor device security extend beyond data loss to direct patient harm. The MHRA and NHS England have both issued guidance on medical device security — and attackers have noticed the gap between guidance and practice.
Over 500,000 connected medical devices operate on NHS networks — the majority run software that cannot be updated and communicates on legacy protocols.
Common Medical Device Security Vulnerabilities
Medical device security vulnerabilities typically fall into several categories: outdated operating systems (many devices run Windows XP Embedded or older embedded Linux with no available updates); default or hardcoded credentials that cannot be changed; unencrypted communication protocols between devices and hospital systems; poor network segmentation allowing device-to-device or device-to-clinical-system lateral movement; and a lack of audit trails that makes unauthorised access difficult to detect. The FDA and MHRA have both issued post-market surveillance guidance requiring manufacturers to address these issues — but the installed base of legacy devices remains a persistent risk.
Securing Medical Devices in NHS and Private Clinical Environments
A pragmatic medical device security programme focuses on what organisations can control: network segmentation (placing medical devices on isolated VLANs with strict firewall rules); asset inventory (you cannot protect what you don't know about — a full register of connected devices, their OS, connectivity, and criticality is the foundation); procurement policy (requiring manufacturers to provide software bills of materials and patch roadmaps for all new devices); monitoring (passive network monitoring to detect anomalous device behaviour without disrupting clinical operations); and incident response (specific playbooks for the scenario where a critical clinical device is suspected of compromise).
Kyanite Blue specialises in cybersecurity for iGaming operators. MGA-licensed operators across Malta trust our stack.
Get in touchReady to secure your iGaming operation?
MGA-licensed operators across Malta trust Kyanite Blue.